World Health Organization WHO gives Emergency Use Listing for Sinovac-CoronaVac vaccine after being found safe, effective and quality assured following two doses of the inactivated vaccine.
Vaccine efficacy results showed that the vaccine prevented symptomatic disease in 51% of those vaccinated and prevented severe COVID-19 and hospitalization in 100% of the studied population.
WHO
WHO Emergency Listing vaccine
- Oxford AstraZeneca/Covishield
- BioNTech-Pfizer
- Sinopharm
- Moderna
- Johnson & Johnson
- Sinovac
Last edited:

